Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic...
REVB had seen 90% drop in 4 months. With breakout on the technicals, the daily could see a test top the LEADING A IC. If the LEADING B is even thought about, that will be close to testing the entire gapfill
This stock has a few factors that lead me to believe it could make a move to the $3 judging by chart indicators. It has been testing the BOLL and IC on the 1min and 4hour since the 15th of March. On the daily it has broken through base IC and what is next would be the upper BOLL. What could make this happen is the MACD cross. The MACD has crossed on the 240...
This stock has seem a dramatic drop in price since January. It went from $11 all the way down to $1. Lately we seen what look to be a floor. With a positive view on the market recent it’s possible we could see upward movement coming from REVB. If this stock even think about going back to IPO levels that would be close to a 10x. If this stock even hits $3 there...
Current News - www.globenewswire.com
This chart is a great example of a gamble. Looking to the left, we see huge potential to return where it came from but the 40% gain today comes from no information. Nothing is driving the increase. We don't see market maker levels of volume either. They may have entered a few weeks ago on the 23rd, but that could also be a huge short position. We don't know...
Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as...